[go: up one dir, main page]

AU2001275083A1 - Compositions containing naphthaquinone and an antiproliferative agent - Google Patents

Compositions containing naphthaquinone and an antiproliferative agent

Info

Publication number
AU2001275083A1
AU2001275083A1 AU2001275083A AU7508301A AU2001275083A1 AU 2001275083 A1 AU2001275083 A1 AU 2001275083A1 AU 2001275083 A AU2001275083 A AU 2001275083A AU 7508301 A AU7508301 A AU 7508301A AU 2001275083 A1 AU2001275083 A1 AU 2001275083A1
Authority
AU
Australia
Prior art keywords
naphthaquinone
compositions containing
antiproliferative agent
antiproliferative
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275083A
Other languages
English (en)
Inventor
Dennis M. Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ChemGenex Pharmaceuticals Inc
Original Assignee
ChemGenex Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ChemGenex Therapeutics Inc filed Critical ChemGenex Therapeutics Inc
Publication of AU2001275083A1 publication Critical patent/AU2001275083A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001275083A 2000-06-01 2001-06-01 Compositions containing naphthaquinone and an antiproliferative agent Abandoned AU2001275083A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20864500P 2000-06-01 2000-06-01
US60/208,645 2000-06-01
PCT/US2001/017677 WO2001091740A2 (fr) 2000-06-01 2001-06-01 Compositions de naphthoquinone et utilisations de celles-ci

Publications (1)

Publication Number Publication Date
AU2001275083A1 true AU2001275083A1 (en) 2001-12-11

Family

ID=22775415

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275083A Abandoned AU2001275083A1 (en) 2000-06-01 2001-06-01 Compositions containing naphthaquinone and an antiproliferative agent

Country Status (4)

Country Link
US (1) US20020040011A1 (fr)
EP (1) EP1289509A2 (fr)
AU (1) AU2001275083A1 (fr)
WO (1) WO2001091740A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
GB0117326D0 (en) 2001-07-16 2001-09-05 Univ Aberdeen Napthoquinone-type inhibitors of protein aggregation
US20050250709A1 (en) * 2003-12-19 2005-11-10 Bionaut Pharmaceuticals Anti-neoplastic agents, combination therapies and related methods
CA2851079A1 (fr) 2005-04-15 2006-10-26 Albert Einstein College Of Medicine Of Yeshiva University Vitamine k destinee a la prevention et au traitement de l'eruption cutanee consequente a une therapie anti-egfr
EP2043685B1 (fr) 2006-07-03 2015-12-23 Genmab A/S Prévention d'une éruption cutanée sur des patients subissant une thérapie anti-egfr
US8815953B2 (en) 2008-03-13 2014-08-26 Spectrum Pharmaceuticals, Inc. Formulations of vitamin K analogs for topical use
WO2012170773A1 (fr) * 2011-06-08 2012-12-13 Edison Pharmaceuticals, Inc. Traitement adjuvant au traitement des maladies mitochondriales avec des quinones et des naphtoquinones
CN109310648B (zh) * 2015-10-27 2022-06-03 杰伊制药公司 用于治疗癌症的包含大麻二酚和第二治疗剂的组合物

Also Published As

Publication number Publication date
US20020040011A1 (en) 2002-04-04
EP1289509A2 (fr) 2003-03-12
WO2001091740A2 (fr) 2001-12-06
WO2001091740A3 (fr) 2003-01-09

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU4866001A (en) Alprazolam inclusion complexes and pharmaceutical compositions thereof
IL155071A0 (en) Glucopyranosyloxybenzylbenzene derivatives and medical compositions containing the same
EP0989459A4 (fr) Composition d'agent de protection amplifiee chimiquement
IL152451A0 (en) 2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
IL153123A0 (en) N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
GB2358256B (en) Chemically amplified positive resist composition
EP1151667A3 (fr) Agent d'activation de plantes
AU2001269175A1 (en) Diamino phenothiazine derivatives and composition comprising same
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001265305A1 (en) Compositions containing hexitol and an antiproliferative agent
AU7816000A (en) Pediculocidal and veterinary compositions
AU2001275083A1 (en) Compositions containing naphthaquinone and an antiproliferative agent
AU2001215831A1 (en) Fragrance compositions
GB0027391D0 (en) Films and compositions
AU2002229654A1 (en) Nanoparticle-containing peeling compositions
AU2002246542A1 (en) Antiproliferative colchicine compositions and uses thereof
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
GB2356941B (en) Chemically amplified positive resist composition
GB9922135D0 (en) Compositions and uses
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001241117A1 (en) Fused-benzoyl derivatives and herbicide compositions containing the same
GB0019768D0 (en) Preservative compounds and compositions